Streetwise Reports Announces 2015 Small-Cap Biotech Watchlist

PETALUMA, CA--(Marketwired - Dec 29, 2014) - Streetwise Reports and Demy Colton/EBD Group announced the 2015 Small-Cap Biotech Watchlist companies in a special feature on The Life Sciences Report. The Watchlist companies are selected by top sector analysts and the list is comprised of the biotech and pharmaceutical companies they are watching to make a move during 2015. These analysts will be discussing the Watchlist in a panel discussion at the Biotech Showcase in San Francisco on January 13.

This marks the third year Streetwise Reports has worked with analysts to create a basket of life sciences companies that can be tracked in real time all year long. "Our publications specialize in sharing insights from top experts in each sector; this adds the dynamic element of a live, graphic way to watch those ideas play out over time." explained President Karen Roche.

This year, the panel features Mara Goldstein, managing director and senior healthcare analyst at Cantor Fitzgerald; Reni Benjamin, head of equity research and senior healthcare analyst at H.C. Wainwright & Co.; Bert Hazlett, managing director of equity research at Ladenburg Thalmann & Co.; Joe Pantginis, head of biotechnology research and senior research analyst at Roth Capital Partners; and George Zavoico, managing director of equity research at MLV & Co.

Readers can subscribe to The Life Sciences Report for free to get updates on the Watchlist and future interviews with the panelists.

Streetwise Reports publishes The Life Sciences Report, in addition to The Gold Report and The Energy Report. These reports feature interviews with experts talking about macro-trends and specific investing ideas in those sectors. Streetwise interviews are syndicated to major retail and institutional investing sites, including the professional investing platforms of Thomson Reuters and Bloomberg. In 2013, Streetwise Reports was named to the Inc. 500/5000 List of America's Fastest Growing Companies for the second year in a row.

Biotech Showcase is an investor and partnering conference co-produced by EMD Group and Demy Colton devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Now in its seventh year, Biotech Showcase is expected to attract upwards of 1,700 attendees.